BIEL (Bioelectronics) OCF Yield %: 0.00 (As of Jun. 30, 2026)


What is Bioelectronics OCF Yield %?

Bioelectronics BIEL OCF Yield % is 0.00 as of Jun. 30, 2026.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Bioelectronics's Trailing 12-Month Cash Flow from Operations is $0.00 Mil, and Market Cap is $6.18 Mil. Therefore, Bioelectronics's OCF Yield % for today is 0.00%.

The historical rank and industry rank for Bioelectronics's OCF Yield % or its related term are showing as below:


BIEL's OCF Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.79
* Ranked among companies with meaningful OCF Yield % only.

Bioelectronics's OCF Margin % for the quarter that ended in . 20 was %.


Bioelectronics OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Bioelectronics OCF Yield % Related Terms


Bioelectronics OCF Yield % Historical Data

* Premium members only.

The historical data trend for Bioelectronics's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioelectronics OCF Yield % Chart

Bioelectronics Annual Data
Trend
OCF Yield %

Bioelectronics Quarterly Data
OCF Yield %

BIEL vs NUVPF, ADMD, RSPI: OCF Yield % Comparison

For the Medical Devices subindustry, Bioelectronics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioelectronics OCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioelectronics's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Bioelectronics's OCF Yield % falls into.



Bioelectronics OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Bioelectronics's OCF Yield % for the fiscal year that ended in . 20 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
= /
=N/A%

Bioelectronics's annualized OCF Yield % for the quarter that ended in . 20 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
= * 4 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
Bioelectronics (BIEL) has a OCF Yield % of 0.00 as of Jun. 30, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bioelectronics and its competitors.
Is Bioelectronics' OCF Yield % too high?
Bioelectronics' current OCF Yield % is 0.00.
How does Bioelectronics' OCF Yield % compare to NUVPF and ADMD?
Bioelectronics' OCF Yield % of 0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median OCF Yield % is 1.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bioelectronics and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioelectronics's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioelectronics stock overvalued right now?
Bioelectronics (BIEL) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Bioelectronics (BIEL), the current OCF Yield % is 0.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioelectronics Business Description

Address 3880 Roundtree Road, Suite 1, Jefferson, MD, USA, 21755
Bioelectronics Corp is an electroceutical company. The company develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Its product line includes Actipatch Musculoskeletal Pain Therapy, Allay menstrual pain therapy, Smart insole heel pain therapy, and Recovery RX post operative and Chronic wounds therapy. It sells its products to wholesale distributors, directly to hospitals and clinics, and to consumers. develops & commercializes electrical stimulation/neuromodulation technology. Company products include RecoveryRx, ActiPatch Musculoskeletal Pain Relief, and Others.